SmallCapReview.com has been a leading site for information on small cap stocks, penny stocks and microcaps since 1999, to receive the free SmallCapReview newsletter and be entered to win a Free iPod Touch visit http://www.smallcapreview.com.
Administaff (NYSE: ASF) $26.06. Today announced results for the second quarter and six months ended June 30, 2010. For the second quarter, the company reported net income of $5.1 million, or $0.20 per diluted share, compared to $5.4 million and $0.22 per diluted share in 2009. For the six months ended June 30, 2010, the company had net income of $7.4 million, or $0.29 per diluted share, compared to $13.6 million and $0.54 in 2009.
Revenues for the second quarter of 2010 increased 2.0% over the 2009 period due to a 5.1%, or $63 increase in revenues per worksite employee per month, offset by a 2.9% decrease in the average number of worksite employees paid per month.
What They Do: Administaff is the nation’s leading professional employer organization (PEO), serving as a full-service human resources department that provides small and medium-sized businesses with administrative relief, big-company benefits, reduced liabilities and a systematic way to improve productivity.
PROLOR Biotech (AMEX: PBTH) $5.95. Today announced publication of a preclinical study in the current on-line edition of the journal Endocrinology showing that human growth hormone (hGH) linked to PROLOR's carboxyl terminal peptide (CTP) technology has significantly increased half-life and bioactivity compared to commercially available hGH. The publication, which is authored by PROLOR researchers, will also be included in the September print edition of Endocrinology.
PROLOR is developing hGH-CTP to provide growth hormone deficient adults and children with growth hormone therapy that requires only once-weekly or bi-monthly injections, rather than the multiple injections per week required by current hGH regimens. PROLOR recently initiated a Phase II clinical trial of hGH-CTP, following a successful Phase I trial that suggested that hGH-CTP, in addition to meeting all safety and tolerability endpoints, could potentially be effective when injected just twice per month.
What They Do: PROLOR Biotech, Inc. is a biopharmaceutical company applying unique technologies, including its patented CTP technology, primarily to develop longer-acting, biobetter, proprietary versions of already-approved therapeutic proteins that currently generate billions of dollars in annual global sales.
Magal Security Systems (Nasdaq: MAGS) $2.97. Announced Sunday that it has received during the past few weeks approximately $5.5 million of orders for projects in Israel and worldwide. The orders from Israel are related to homeland security and have been received from existing customers for new sites and expansions, as well as follow on support.
Two of the orders consisting of $1.2 million in the aggregate are to protect overseas critical infrastructure. One order is for a taut wire solution for the perimeter of a large air-force base in Western Europe. The second order is for a comprehensive solution for a nuclear reactor in North America. The project in North America includes Magal's leading PIDS (Perimeter Intrusion Detection System) buried cable technology and Dreambox - Magal's outdoor video management system with the state-of-the-art Intelligent Video Analytics (IVA).
What They Do: Magal S3 is a leading international provider of security, safety and site management solutions and products. Over the past 40 years, Magal S3 has delivered tailor-made solutions to hundreds of satisfied customers in over 80 countries.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com is a leading site for news on small-caps, penny stocks and microcaps. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select stocks in play, to register visit http://www.smallcapreview.com.
